Don't anybody get excited, this dog ain't gonna hunt for quite awhile.
I say that based on the ridiculously low profit projections in the new IGXT PDF presentation. Full year 2014 (yes 2014) only $7 million profit from CPI-300 royalties, and that's obviously calculated using Edgemont's marketing strategy as they are part of the same updated PDF.
There is no catalyst to move this stock up now until maybe news about the PAR bioavailability work and/or the Red Hill migraine project. Neither of which you will hear anything about for months. Sorry but I'm outta here for now, will look at it again after any PAR / Red Hill news. Won't really lose much money per se (averaged in around $0.51), it's just the frustration of knowing they have something really significant but don't seem to know anything about how to promote a stock. Even a profit projection half of what I think is possible in 2014 from CPI-300 royalties ($40-45 million), combined with the humblest promotion of their stock would shoot this up to $2. Right now it has an outside chance of getting back up to around $0.70 over the next 6 months or so (recent highs with FDA approval and a couple of weeks ago), but IMO even that will be tough.
Only near term possibility is someone comes in and offers them $2-2.25 a share. It would be an absolute steal, but there would be nothing Zerbe or the board could do about it. Not with the way they have absolutely destroyed / crushed investor enthusiasm / expectations with how the Edgemont announcement was handled, and now this $7 million in 2014 projection. $7 million in 2014 would have a hard time supporting a $1-2 share price, so why not take a sure money buyout now if it's offered. IGXT management (especially Zerbe) would get screwed here if someone pulls off a $2 takeover. All due to their complete lack of competence in how to play the communication game. So sad.
This management / PR combination would probably offer a buy-one-get-one-free promotion selling water in the desert.
